Josef Chovanec
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Zuzana Dostálová (3 shared papers)Anna Vašků (2 shared papers)Julie Bienertová Vašků (2 shared papers)Jolana Lipková (1 shared paper)Rudolf Nenutil (3 shared papers)Lenka Zdražilová Dubská (2 shared papers)Estrid Høgdall (2 shared papers)Claus Høgdall (2 shared papers)
In The Last Decade
Josef Chovanec
19 papers receiving 267 citations
Peers
Comparison fields: 5 of 62
- Reproductive Medicine 90
- Obstetrics and Gynecology 69
- Oncology 86
- Cancer Research 45
- Immunology 58
Countries citing papers authored by Josef Chovanec
This map shows the geographic impact of Josef Chovanec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Chovanec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Chovanec more than expected).
Fields of papers citing papers by Josef Chovanec
This network shows the impact of papers produced by Josef Chovanec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Chovanec. The network helps show where Josef Chovanec may publish in the future.
Co-authors
The 25 scholars most cited alongside Josef Chovanec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 79 | |
| 2 | 2011 | 53 | |
| 3 | 2022 | 31 | |
| 4 | 2020 | 19 | |
| 5 | Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group. | 2000 | 15 |
| 6 | 2019 | 14 | |
| 7 | 2013 | 10 | |
| 8 | 2010 | 10 | |
| 9 | Leptin--2548 g/A polymorphism in endometrial cancer. | 2009 | 10 |
| 10 | 2013 | 8 | |
| 11 | 2017 | 6 | |
| 12 | [Sentinel lymph node identification using hysteroscopy in patients with endometrial cancer]. | 2010 | 6 |
| 13 | 2020 | 5 | |
| 14 | 2025 | 3 | |
| 15 | 2019 | 2 | |
| 16 | 2011 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2013 | 1 | |
| 19 | Přehled diagnostiky a léčby karcinomu děložního hrdla | 2014 | 1 |
| 20 | 2017 | 0 |
About Josef Chovanec
Josef Chovanec is a scholar working on Oncology, Immunology, Reproductive Medicine, Surgery and Obstetrics and Gynecology, having authored 23 papers that have together received 275 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (4 papers), Immunotherapy and Immune Responses (4 papers), Virus-based gene therapy research (2 papers), Urinary and Genital Oncology Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cervical Cancer and HPV Research (2 papers) and Genital Health and Disease (2 papers). The work is most often cited by research in Reproductive Medicine (90 citations), Obstetrics and Gynecology (69 citations), Oncology (86 citations), Cancer Research (45 citations) and Immunology (58 citations). Josef Chovanec has collaborated with scholars based in Czechia, Poland and Germany. Frequent co-authors include Zuzana Dostálová, Anna Vašků, Julie Bienertová Vašků, Jolana Lipková, Rudolf Nenutil, Lenka Zdražilová Dubská, Estrid Høgdall, Claus Høgdall, Adam N. Rosenthal and Grigorios Kalapotharakos. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Journal for ImmunoTherapy of Cancer, Journal of Proteomics and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.